Test Variability of the QuantiFERON-TB Gold In-Tube Assay in Clinical Practice
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
RATIONALE: Although IFN-γ release assays (IGRAs) are widely used to screen for Mycobacterium tuberculosis infection in high-income countries, published data on repeatability are limited. OBJECTIVES: To determine IGRA repeatability. METHODS: The study population included consecutive patients referred to The Methodist Hospital (Houston, TX) between August 1, 2010 and July 31, 2011 for latent tuberculosis (TB) infection screening with an IGRA (QuantiFERON-TB Gold In-Tube; Cellestis, Carnegie, Australia). We performed multiple IGRA tests using leftover stimulated plasma according to a prospectively formulated quality control protocol. We analyzed agreement in interpretation of test results classified according to manufacturer-recommended criteria and repeatability of quantitative TB response. MEASUREMENTS AND MAIN RESULTS: During the study period, 1,086 test results were obtained from 543 subjects. Per the manufacturer's cut-point, the result of the second test was discordant from that of the first in 28 (8%) of 366 patients with valid test results, including 13 with an initial negative result and 15 with an initial positive result. Although agreement between repeat test results was high (κ = 0.84; 95% confidence interval, 0.79-0.90), the normal expected range of within-subject variability in TB response on retesting included differences of ± 0.60 IU/ml for all individuals (coefficient of variation, 14%), and ± 0.24 IU/ml (coefficient of variation, 27%) for individuals whose initial TB response was between 0.25 and 0.80 IU/ml. CONCLUSIONS: There is substantial variability in TB response when IGRAs are repeated using the same patient sample. IGRA results should be interpreted cautiously when TB response is near interpretation cut-points.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
American society for testing and materials
Mather, B., & Etris, S. F. (2006) · Encyclopedia of Earth Science · doi:10.1007/0-387-30720-6_5 · Cited by 5,558
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,748
Mazurek, G. H., Jereb, J., Vernon, A. A., LoBue, P. A., GOLDBERG, S. V., & Castro, K. G. (2010) · PubMed · Cited by 1,417
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
(2016) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020190-part06-targeted · Cited by 920
An Approach to the Analysis of Repeated Measurements
Diggle, P. J. (1988) · Biometrics · doi:10.2307/2531727 · Cited by 490
Interpretation of Repeated Tuberculin Tests: Boosting, Conversion, and Reversion
MENZIES, D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9801120 · Cited by 488 · cited 1×
“Ultimately, as with the TST, conversion thresholds will depend on risk of future active TB disease, the epidemiologic setting, and, possibly, the magnitude of the quantitative response (44), although establishing the evidence base for such thresholds will be challenging (2).”
Background(2000) · PubMed · Cited by 486
Evaluation of diagnostic tests for infectious diseases: general principles
Banoo, S., Bell, D., Bossuyt, P., Herring, A., Mabey, D., Poole, F., Smith, P. G., Sriram, N., Wongsrichanalai, C., Linke, R., et al. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1523 · Cited by 454
Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ Assay
Pai, M., Joshi, R., Dogra, S., Mendiratta, D. K., Narang, P., Kalantri, S., Reingold, A. L., Colford, J. M., Riley, L. W., & Menzies, D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-472oc · Cited by 275
Zwerling, A. A., van den Hof, S., Scholten, J. N., Cobelens, F. G. J., Menzies, D., & Pai, M. (2011) · Thorax · doi:10.1136/thx.2010.143180 · Cited by 275 · cited 1×
“Although IGRAs may be more specific than the TST and initially identify fewer persons requiring preventive therapy in some settings (38), subsequent conversions and reversions may occur with greater frequency (7, 11, 39, 40).”
Backgroundvan Zyl-Smit, R. N., Zwerling, A., Dheda, K., & Pai, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008517 · Cited by 201
van Zyl-Smit, R. N., Pai, M., Peprah, K., Meldau, R., Kieck, J., Juritz, J., Badri, M., Zumla, A., Sechi, L. A., Bateman, E. D., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1704oc · Cited by 188
Assessing Reproducibility by the Within-Subject Coefficient of Variation with Random Effects Models
Quan, H., & Shih, W. J. (1996) · Biometrics · doi:10.2307/2532835 · Cited by 152 · cited 1×
“4%) during the FDA approval process, because their estimate was based on a small number of subjects who had evidence of active TB and were likely to have had high mean TB response (5); low CV percent despite relative large differences in magnitude of TB response among high positive tests is a known limitation of this…”
BackgroundSerial Testing for Tuberculosis: Can We Make Sense of T Cell Assay Conversions and Reversions?
Pai, M., & O'Brien, R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040208 · Cited by 138
Evaluation of diagnostic tests for infectious diseases: general principles
Banoo, S., Bell, D., Bossuyt, P. M., Herring, A. J., Mabey, D. C. W., Poole, F., Smith, P. G., Sriram, N., Wongsrichanalai, C., Linke, R., et al. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1570 · Cited by 130 · cited 1×
“Data on test imprecision, including repeatability (serial testing under identical conditions) and reproducibility (serial testing under changed conditions) (3) (see Table 1), are required for CE (Conformité Européene) Marking in the European Union and for premarket approval of in vitro diagnostic tests by the US Food…”
MethodComparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
van Zyl-Smit, R. N., Binder, A. B., Meldau, R., Mishra, H. K., Semple, P. L., Theron, G., Peter, J., Whitelaw, A. C., Sharma, S. K., Warren, R. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028815 · Cited by 126 · cited 1×
“, Sunnyvale, CA) quantitative polymerase chain reaction (CV 6%) (48), or commonly used serologic assays (17).”
MethodVeerapathran, A., Joshi, R. P., Goswami, K., Dogra, S., Moodie, E. E. M., Reddy, M. V. R., Kalantri, S., Schwartzman, K., Behr, M. A., Menzies, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001850 · Cited by 104 · cited 1×
“In India, Veerapathran and coworkers (8) used log transformation and linear mixed effects analysis to determine that “a second test performed on the same blood sample will.”
MethodTuberculin test. Variability with the Mantoux procedure.
Chaparas, S. D., Vandiviere, H. M., Melvin, I. G., Koch, G. G., & Becker, C. (1985) · PubMed · doi:10.1164/arrd.1985.132.1.175 · Cited by 95
Reproducibility of QuantiFERON-TB Gold In-Tube Assay
Perry, S., Sanchez, L. H. G., Yang, S., Agarwal, Z., Hurst, P., & Parsonnet, J. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00398-07 · Cited by 94
Porsa, E., Cheng, L., Seale, M. M., Delclos, G. L., Ma, X., Reich, R. A., Musser, J. M., & Graviss, E. A. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.1.53-58.2006 · Cited by 77
Self-citationRingshausen, F. C., Nienhaus, A., Costa, J. T., Knoop, H., Schlösser, S., Schultze‐Werninghaus, G., & Rohde, G. G. U. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05058-11 · Cited by 74 · cited 12×
“The 2010 Centers for Disease Control and Prevention Guidelines on IGRAs recommend that clinical laboratories report quantitative in addition to qualitative (i.e., positive or negative) test TABLE 4.”
BackgroundInfluentialA STUDY OF VARIABILITY IN TUBERCULIN TEST READING.
Bearman, J. E., Kleinman, H., GLYER, V. V., & LACROIX, O. M. (1964) · PubMed · doi:10.1164/arrd.1964.90.6.913 · Cited by 73
Temporal Dynamics of Interferon Gamma Responses in Children Evaluated for Tuberculosis
Herrmann, J., Belloy, M., Porcher, R., Simonney, N., Taam, R. A., Bourgeois, M. L., Gaudelus, J., LosAngeles, L. D., Chadelat, K., Scheinmann, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004130 · Cited by 62 · cited 12×
“The 2010 Centers for Disease Control and Prevention Guidelines on IGRAs recommend that clinical laboratories report quantitative in addition to qualitative (i.e., positive or negative) test TABLE 4.”
BackgroundInfluentialDiscordance among Commercially Available Diagnostics for Latent Tuberculosis Infection
Mancuso, J. D., Mazurek, G. H., Tribble, D. R., Olsen, C. H., Aronson, N., Geiter, L. J., Goodwin, D. J., & Keep, L. W. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1244oc · Cited by 58 · cited 1×
“Indeed, recognizing the limited positive predictive value of IGRAs in low-risk individuals (41), some centers in the United States have already instituted such policies (42, 43).”
BackgroundEvaluation of Elispot assays: influence of method and operator on variability of results
Janetzki, S., Schaed, S. G., Blachère, N. E., Ben‐Porat, L., Houghton, A. N., & Panageas, K. S. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.008 · Cited by 49
Lee, K., Han, M. K., Choi, H. R., Choi, C., Oh, Y., Lee, S., Kim, W. S., Kim, D. S., Woo, J. H., & Shim, T. S. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/648082 · Cited by 45
Evaluation of Quantitative IFN-γ Response for Risk Stratification of Active Tuberculosis Suspects
Metcalfe, J. Z., Cattamanchi, A., Vittinghoff, E., Ho, C. S., Grinsdale, J. A., Hopewell, P. C., Kawamura, L. M., & Nahid, P. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0981oc · Cited by 41
Self-citationUnusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests
Powell, R. D., Whitworth, W. C., Bernardo, J., Moonan, P. K., & Mazurek, G. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020061 · Cited by 34
Tuberculosis infection in drug users: interferon-gamma release assay performance.
Grimes, C. Z., Hwang, L.-Y., Williams, M. L., Austin, C., & Graviss, E. A. (2007) · PubMed · Cited by 23
Self-citation
Cited by
Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw694 · Cited by 992
“While the variations were quantitatively modest, results at or near the cutoff resulted in differing test results [52].”
ResultGamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K., et al. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-13 · Cited by 886
Self-citation
Metadata
- Authors
- Metcalfe, J. Z., Cattamanchi, A., McCulloch, C. E., Lew, J. D., Ha, N. P., & Graviss, E. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-15
- Volume
- 187
- Issue
- 2
- Pages
- 206-211
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2166932611
- Cited by
- 191
- References
- 33
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.